|
1
|
Lim H, Devesa SS, Sosa JA, Check D and
Kitahara CM: Trends in thyroid cancer incidence and mortality in
the United States, 1974–2013. JAMA. 317:1338–1348. 2017. View Article : Google Scholar
|
|
2
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM and
Schlumberger M: 2015 American thyroid association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The American thyroid association
guidelines task force on thyroid nodules and differentiated thyroid
cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar
|
|
3
|
Acosta-Ortega J, Montalbán-Romero S,
García-Solano J, Sánchez- Sánchez C and Pérez-Guillermo M:
Simultaneous medullary carcinoma of the thyroid gland and Hodgkin’s
lymphoma in bilateral lymph nodes of the neck: A potential pitfall
in fine-needle aspiration cytology. Diagn Cytopathol. 31:255–258.
2004. View
Article : Google Scholar
|
|
4
|
Falls DL: Neuregulins: Functions, forms,
and signaling strategies. Exp Cell Res. 284:14–30. 2003. View Article : Google Scholar
|
|
5
|
Stefansson H, Steinthorsdottir V,
Thorgeirsson TE, Gulcher JR and Stefansson K: Neuregulin 1 and
schizophrenia. Ann Med. 36:62–71. 2004. View Article : Google Scholar
|
|
6
|
Wadugu B and Kühn B: The role of
neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on
effects on cardiomyocyte proliferation. Am J Physiol Heart Circ
Physiol. 302:H2139–H2147. 2012. View Article : Google Scholar
|
|
7
|
Sheean ME, McShane E, Cheret C, Walcher J,
Müller T, Wulf-Goldenberg A, Hoelper S, Garratt AN, Krüger M and
Rajewsky K: Activation of MAPK overrides the termination of myelin
growth and replaces Nrg1/ErbB3 signals during Schwann cell
development and myelination. Genes Dev. 28:290–303. 2014.
View Article : Google Scholar
|
|
8
|
Cheng H, Terai M, Kageyama K, Ozaki S,
McCue PA, Sato T and Aplin AE: Paracrine effect of NRG1 and HGF
drives resistance to MEK inhibitors in metastatic uveal melanoma.
Cancer Res. 75:2737–2748. 2015. View Article : Google Scholar
|
|
9
|
Vyas S, Zaganjor E and Haigis MC:
Mitochondria and cancer. Cell. 166:555–566. 2016. View Article : Google Scholar
|
|
10
|
Gorrini C, Harris IS and Mak TW:
Modulation of oxidative stress as an anticancer strategy. Nat Rev
Drug Discov. 12:931–947. 2013. View
Article : Google Scholar
|
|
11
|
Sena LA and Chandel NS: Physiological
roles of mitochondrial reactive oxygen species. Mol Cell.
48:158–167. 2012. View Article : Google Scholar
|
|
12
|
Favaro E, Bensaad K, Chong MG, Tennant DA,
Ferguson DJ, Snell C, Steers G, Turley H, Li JL and Günther UL:
Glucose utilization via glycogen phosphorylase sustains
proliferation and prevents premature senescence in cancer cells.
Cell Metab. 16:751–764. 2012. View Article : Google Scholar
|
|
13
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE and Wong M: Association of
reactive oxygen species levels and radioresistance in cancer stem
cells. Nature. 458:780–783. 2009. View Article : Google Scholar
|
|
14
|
Li W and Kong AN: Molecular mechanisms of
Nrf2-mediated antioxidant response. Mol Carcinog. 48:91–104. 2009.
View Article : Google Scholar
|
|
15
|
Taguchi K, Motohashi H and Yamamoto M:
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response
and cancer evolution. Genes Cells. 16:123–140. 2011. View Article : Google Scholar
|
|
16
|
He H, Li W, Liyanarachchi S, Wang Y, Yu L,
Genutis LK, Maharry S, Phay JE, Shen R, Brock P and de la Chapelle
A: The role of NRG1 in the predisposition to papillary thyroid
carcinoma. J Clin Endocrinol Metab. Nov 7–2017.Epub ahead of
print.
|
|
17
|
Jendrzejewski J, Liyanarachchi S, Nagy R,
Senter L, Wakely PE, Thomas A, Nabhan F, He H, Li W and Sworczak K:
Papillary thyroid carcinoma: Association between germline DNA
variant markers and clinical parameters. Thyroid. 26:1276–1284.
2016. View Article : Google Scholar
|
|
18
|
Rogounovitch TI, Bychkov A, Takahashi M,
Mitsutake N, Nakashima M, Nikitski AV, Hayashi T, Hirokawa M,
Ishigaki K and Shigematsu K: The common genetic variant rs944289 on
chromosome 14q13.3 associates with risk of both malignant and
benign thyroid tumors in the Japanese population. Thyroid.
25:333–340. 2015. View Article : Google Scholar
|
|
19
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. 8th. Springer;
Chicago, IL: 2017, View Article : Google Scholar
|
|
20
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR and Freshney RI: Check your cultures! A list of
cross-contaminated or misidentified cell lines. Int J Cancer.
127:1–8. 2010. View Article : Google Scholar
|
|
21
|
Ribeiro FR, Meireles AM, Rocha AS and
Teixeira MR: Conventional and molecular cytogenetics of human
non-medullary thyroid carcinoma: Characterization of eight cell
line models and review of the literature on clinical samples. BMC
Cancer. 8:3712008. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Shi RL, Qu N, Liao T, Wang YL, Wang Y, Sun
GH and Ji QH: Expression, clinical significance and mechanism of
Slit2 in papillary thyroid cancer. Int J Oncol. 48:2055–2062. 2016.
View Article : Google Scholar
|
|
24
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar
|
|
25
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar
|
|
26
|
Jaramillo MC and Zhang DD: The emerging
role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev.
27:2179–2191. 2013. View Article : Google Scholar
|
|
27
|
Hayes AJ, Skouras C, Haugk B and Charnley
RM: Keap1-Nrf2 signalling in pancreatic cancer. Int J Biochem Cell
Biol. 65:288–299. 2015. View Article : Google Scholar
|
|
28
|
Zhou S, Ye W, Shao Q, Zhang M and Liang J:
Nrf2 is a potential therapeutic target in radioresistance in human
cancer. Crit Rev Oncol Hematol. 88:706–715. 2013. View Article : Google Scholar
|
|
29
|
Jiang P, Du W, Mancuso A, Wellen KE and
Yang X: Reciprocal regulation of 53 and malic enzymes modulates
metabolism and senescence. Nature. 493:689–693. 2013. View Article : Google Scholar
|
|
30
|
Dai B, Yoo SY, Bartholomeusz G, Graham RA,
Majidi M, Yan S, Meng J, Ji L, Coombes K and Minna JD:
KEAP1-dependent synthetic lethality induced by AKT and TXNRD1
inhibitors in lung cancer. Cancer Res. 73:5532–5543. 2013.
View Article : Google Scholar
|
|
31
|
Lien EC, Lyssiotis CA, Juvekar A, Hu H,
Asara JM, Cantley LC and Toker A: Glutathione biosynthesis is a
metabolic vulnerability in PI(3)K/Akt-driven breast cancer. Nat
Cell Biol. 18:572–578. 2016. View
Article : Google Scholar
|
|
32
|
Piantadosi CA, Withers CM, Bartz RR,
MacGarvey NC, Fu P, Sweeney TE, Welty-Wolf KE and Suliman HB: Heme
oxygenase-1 couples activation of mitochondrial biogenesis to
anti-inflammatory cytokine expression. J Biol Chem.
286:16374–16385. 2011. View Article : Google Scholar
|
|
33
|
Ross D and Siegel D: NAD(P)H:quinone
oxidoreductase 1 (NQO1, DT-diaphorase), functions and
pharmacogenetics. Methods Enzymol. 382:115–144. 2004. View Article : Google Scholar
|
